Literature DB >> 10155289

A proposal for Italian guidelines in pharmacoeconomics The Mario Negri Institute Centre for Health Economics.

L Garattini, R Grilli, D Scopelliti, L Mantovani.   

Abstract

Mesh：

Year:  1995        PMID： 10155289     DOI： 10.2165/00019053-199507010-00001

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  11 in total

1.  Discounting in cost-effectiveness analysis of healthcare programmes.

Authors:  D A Katz; H G Welch
Journal:  Pharmacoeconomics       Date:  1993-04       Impact factor: 4.981

2.  Guidelines for economic analysis of pharmaceutical products: a draft document for Ontario and Canada.

Authors:  A S Detsky
Journal:  Pharmacoeconomics       Date:  1993-05       Impact factor: 4.981

Review 3.  Cost effectiveness/utility analyses. Do current decision rules lead us to where we want to be?

Authors:  S Birch; A Gafni
Journal:  J Health Econ       Date:  1992-10       Impact factor: 3.883

Review 4.  Pragmatic versus explanatory trials.

Authors:  K D MacRae
Journal:  Int J Technol Assess Health Care       Date:  1989       Impact factor: 2.188

Review 5.  Measurement of health state utilities for economic appraisal.

Authors:  G W Torrance
Journal:  J Health Econ       Date:  1986-03       Impact factor: 3.883

6.  Economic analysis alongside clinical trials. Revisiting the methodological issues.

Authors:  M F Drummond; L Davies
Journal:  Int J Technol Assess Health Care       Date:  1991       Impact factor: 2.188

7.  Castigating QALYs.

Authors:  J Rawles
Journal:  J Med Ethics       Date:  1989-09       Impact factor: 2.903

Review 8.  Meta-analysis in clinical research.

Authors:  K A L'Abbé; A S Detsky; K O'Rourke
Journal:  Ann Intern Med       Date:  1987-08       Impact factor: 25.391

Review 9.  Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis.

Authors:  A Briggs; M Sculpher; M Buxton
Journal:  Health Econ       Date:  1994 Mar-Apr       Impact factor: 3.046

10.  Foundations of cost-effectiveness analysis for health and medical practices.

Authors:  M C Weinstein; W B Stason
Journal:  N Engl J Med       Date:  1977-03-31       Impact factor: 91.245
View more
  22 in total

1.  Using economic evaluations to make formulary coverage decisions. So much for guidelines.

Authors:  A H Anis; Y Gagnon
Journal:  Pharmacoeconomics       Date:  2000-07       Impact factor: 4.981

2.  A reappraisal of economic evaluation of pharmaceuticals. Science or marketing?

Authors:  M F Drummond
Journal:  Pharmacoeconomics       Date:  1998-07       Impact factor: 4.981

3.  Reporting format for economic evaluation. Part I: Application to the Dutch healthcare system.

Authors:  M J Nuijten; M J Brorens; Y A Hekster; A van der Kuy; J H Lockefeer; P A de Smet; G Bonsel; M H Pronk
Journal:  Pharmacoeconomics       Date:  1998-08       Impact factor: 4.981

4.  Pharmacoeconomics in the new millennium. A pharmaceutical industry perspective.

Authors:  R Thwaites; R J Townsend
Journal:  Pharmacoeconomics       Date:  1998-02       Impact factor: 4.981

Review 5.  Why training is the key to successful guideline implementation.

Authors:  A D Paltiel; P J Neumann
Journal:  Pharmacoeconomics       Date:  1997-09       Impact factor: 4.981

6.  The decision rules of cost-effectiveness analysis.

Authors:  G Karlsson; M Johannesson
Journal:  Pharmacoeconomics       Date:  1996-02       Impact factor: 4.981

7.  Sensitivity analysis in health economic and pharmacoeconomic studies. An appraisal of the literature.

Authors:  K E Agro; C A Bradley; N Mittmann; M Iskedjian; A L Ilersich; T R Einarson
Journal:  Pharmacoeconomics       Date:  1997-01       Impact factor: 4.981

8.  Economic evaluation of an educational campaign for early diagnosis of cutaneous melanoma.

Authors:  L Garattini; T Cainelli; G Tribbia; D Scopelliti
Journal:  Pharmacoeconomics       Date:  1996-02       Impact factor: 4.981

9.  Providing systematic guidance in pharmacoeconomic guidelines for analysing costs.

Authors:  Philip Jacobs; Arto Ohinmaa; Bruce Brady
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 10.  Pharmacoeconomic studies in Italy: a critical review of the literature.

Authors:  D Cornago; L Li Bassi; P De Compadri; L Garattini
Journal:  Eur J Health Econ       Date:  2006-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.